Skip to main content
. Author manuscript; available in PMC: 2021 Oct 1.
Published in final edited form as: Eur J Pharm Sci. 2020 Jul 23;153:105488. doi: 10.1016/j.ejps.2020.105488

Table 1.

Summary of metabolites of ATX in HLM, MLM, RLM, and mice.

RT (min) Observed m/z [M+H]+ Calculated m/z [M+H]+ Mass error (ppm) Predicted molecular formula Identification Metabolite ID* Source
6.83 256.1695 256.1696 −0.39 C17H22NO Atomoxetine ATX HLM, MLM, RLM, serum, liver, urine, feces
4.43 272.1645 272.1645 0.0 C17H22NO2 O+ATX M1 HLM, MLM, RLM
5.16 272.1647 272.1645 0.74 C17H22NO2 O+ATX M2 HLM, MLM, RLM, serum, liver, urine, feces
5.64 272.1644 272.1645 −0.37 C17H22NO2 O+ATX M3 HLM, MLM, RLM, serum liver, urine, feces
7.45 272.1646 272.1645 0.37 C17H22NO2 O+ATX (N-hydroxylation) M4 HLM, MLM, RLM
6.66 242.1540 242.1539 0.42 C16H20NO ATX (−CH3) M5 HLM, MLM, RLM, liver, urine
4.50 258.1491 258.1489 0.78 C16H20NO2 O+ATX (−CH3) M6 HLM, MLM, RLM
4.71 258.1490 258.1489 0.39 C16H20NO2 O+ATX (−CH3) M7 HLM, MLM, RLM
5.00 258.1489 258.1489 0 C16H20NO2 O+ATX (−CH3) M8 HLM, MLM, RLM, urine, liver
5.45 258.1490 258.1489 0.39 C16H20NO2 O+ATX (−CH3) M9 HLM, MLM, RLM, urine, liver
5.93 286.1439 286.1438 0.35 C17H20NO3 ATX-Acid M10 HLM, MLM, RLM, liver, serum, urine, feces
5.49 272.1283 272.1281 0.73 C16H18NO3 ATX-Acid (−CH3) M11 HLM, MLM, RLM, liver
4.96 302.1390 302.1387 0.99 C17H20NO4 O+ATX-Acid M12 MLM
5.18 302.1389 302.1387 0.66 C17H20NO4 O+ATX-Acid M13 MLM
5.93 284.1283 284.1281 0.70 C17H18NO3 Cyclization M14 HLM, MLM, RLM
7.80 284.1282 284.1281 0.35 C17H18NO3 Cyclization M15 HLM, MLM, RLM, liver, urine, feces
4.47 288.1593 288.1594 −0.35 C17H22NO3 2O+ATX M16 HLM, MLM, RLM, urine, feces, liver
4.73 288.1592 288.1594 −0.69 C17H22NO3 2O+ATX M17 HLM, MLM, RLM, urine, liver, feces
5.16 288.1595 288.1594 0.35 C17H22NO3 2O+ATX M18 HLM, MLM, RLM, urine
5.69 288.1594 288.1594 0.0 C17H22NO3 2O+ATX M19 HLM, MLM, RLM
2.48 166.1228 166.1226 1.20 C10H16NO De-toluene M20 HLM, MLM, RLM, urine, liver
4.15 448.1968 448.1966 0.45 C23H30NO8 O+ATX+Glu M21 urine, liver, serum
5.43 448.1969 448.1966 0.67 C23H30NO8 O+ATX+Glu M22 urine, liver, serum
4.01 434.1811 434.1809 0.46 C22H28NO8 O+ATX+Glu (−CH3) M23 urine, liver, serum
3.73 462.1760 462.1759 0.22 C23H28NO9 ATX-Acid+Glu M24 urine
3.39 464.1918 464.1915 0.65 C23H30NO9 2O+ATX+Glu M25 urine
3.64 464.1916 464.1915 0.2 C23H30NO9 2O+ATX+Glu M26 urine, liver, serum
3.97 464.1919 464.1915 0.86 C23H30NO9 2O+ATX+Glu M27 urine
4.23 464.1915 464.1915 0.0 C23H30NO9 2O+ATX+Glu M28 urine liver, serum
4.09 610.2496 610.2494 0.33 C29H40NO13 O+ATX+Glu+Gluc M29 urine
6.95 299.1756 299.1754 0.67 C18H23N2O2 ATX_hydrazone M30 HLM, MLM, RLM
5.53 315.1709 315.1703 −1.9 C18H23N2O3 O+ATX_hydrazone M31 MLM, RLM

ATX, atomoxetine; Glu, glucuronic acid; Gluc, glucose; −CH3, demethylation; O+, monohydroxylation; 2O+, dihydroxylation; Acid, carboxylic acid; HLM, MLM, RLM, human, mouse, and rat liver microsmes.

*

, novel metabolites indicated by red.